US FDA grants efanesoctocog alfa breakthrough therapy designation for hemophilia A
The designation is based on Xtend-1 phase-III study data demonstrating a clinically meaningful prevention of bleeds and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
hemophilia A
US antitrust enforcers give Roche approval to buy Spark Therapeutics
The FTC approved the deal, which was originally announced in February, without requiring any asset sales to ensure that the…